Page 12 - Morphosys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Today - Breaking & Trending Today

JPMorgan sees high potential in Morphosys

U.S. bank JPMorgan is giving antibody specialist Morphosys plenty of advance praise months before the crucial data readout on its cancer drug pelabresib. More likely than failure is that the trial. | June 16, 2023 ....

United States , James Gordon , Constellation Pharmaceuticals , Morphosys Ag Stock Exchange , Press Release , He Mor De0006632003 ,

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide. | June 14, 2023 ....

United States , Jp Morgan Capital Holdings , Third Party , Jp Morgan International Finance , Jp Morgan Securities , Distribution Services , Jpmorgan Chase Co , National Association , Jpmorgan Chase Bank , Notification Of Major Holdings , Jpmorgan Chase Holdings , Dealer Holdings Inc , Rights Announcement , Voting Rights Announcement , Entity Identifier , Chase Bank , Chase Holdings , Regulatory Announcements , Corporate News , Morphosys Ag Stock Exchange , Press Release , F Mor De0006632003 ,

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide. | June 7, 2023 ....

Frankfurt Am Main , Notification Of Major Holdings , Distribution Services , Rights Announcement , Voting Rights Announcement , Entity Identifier , Regulatory Announcements , Corporate News , Morphosys Ag Stock Exchange , Press Release , F Mor De0006632003 ,

MorphoSys AG (NASDAQ:MOR) Receives $9.97 Consensus Price Target from Analysts

Shares of MorphoSys AG (NASDAQ:MOR – Get Rating) have been given an average rating of “Hold” by the eight brokerages that are covering the firm, MarketBeat reports. Five research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The […] ....

Morphosys Company Profile , Optiver Holding , T Rowe Price Investment Management Inc , Opaleye Management Inc , Td Asset Management Inc , Get Rating , Capital Management , Management Inc , Price Investment Management , Morphosys Daily , Nasdaq Mor ,

MorphoSys To Release Myelofibrosis Trial Data This Year

Shares of MorphoSys AG (MOR), which have been experiencing strong momentum this year, touched a new 52-week high of $6.85 during intraday trading yesterday.. ....

United Kingdom , Lenalidomide Revlimid , Incyte Jakafi , Incyte Corp , Nasdaq Global Market , Blood Cancer , Bone Marrow ,